HDAC9 and colorectal cancer: In the current study,we have demonstratedthe capability to generate PLGA nanoparticles that coencapsulate theMDM2 antagonist RG7388 and the Class-I HDAC inhibitor Entinostat ata controlled ratio that elicits synergistic cell death in a panelof colorectal cancer cell models.